Variability within investigations of intravenous colistin: The scope of the problem

Clinical Infectious Diseases

Volumn 58, Issue 9, 2014, Pages 1340-1342

  Gauthier, Timothy P ^a   Lantz, Evan ^b   Frederick, Corey ^b   Masmouei, Hoda ^a   Ruiz Serrano, Larisa ^a   Smith, Laura ^b   Wolowich, William R ^a   Abbo, Lilian M ^c  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; COLISTIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; GREECE; HUMAN; INTERNATIONAL STANDARD UNIT; KIDNEY INJURY; LETTER; MEDICATION ERROR; MORTALITY; NEPHROTOXICITY; NORTH AMERICA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

ANTI-BACTERIAL AGENTS; COLISTIN; HUMANS;

EID: 84898896810     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu061     Document Type: Letter

References (3)

1. Nation RL, Li J, Cars O, et al. Consistent global approach on reporting of colistin doses to promote safe and effective use. Clin Infect Dis 2013; 58:139-41
2. AIDA Project. Fact sheets. Available at: Http:// www.aida-project.eu/ back-ground-information/ fact-sheets. Accessed 14 January 2014
3. American Society of Health System Pharmacists. Warning! Dosing confusion with colistimethate for injection. Available at: Http://www. ashp.org/DocLibrary/Policy/PatientSafety/ NANAlert-Colistimethatesodium.aspx. Accessed 14 January 2014.